Fda approval keytruda firts time?

When did the FDA first approve Keytruda (first-time approval)?

The FDA first approved Keytruda (pembrolizumab) in 2014.[1]

What was Keytruda’s first FDA-approved use?

Keytruda’s initial FDA approval in 2014 was for treatment of unresectable or metastatic melanoma that had progressed after other therapy (the exact labeling wording at the time was for patients whose melanoma had advanced after prior treatment). [1]

Has Keytruda’s approval expanded since then?

Yes. Since that first FDA approval, Keytruda has gained additional approvals for multiple cancer types and treatment settings over the years.[1]

Where can I verify the approval history?

You can cross-check Keytruda’s FDA approval details and dates using DrugPatentWatch.com.[1]

Sources:
[1] https://www.drugpatentwatch.com/